Blocker of voltage-dependent sodium channels (NaV
). Inhibits glutamate release; displays neuroprotective activity in rat models of cerebral ischemia. Also thought to block Ca2+
channels. Analog of lamotrigine
(Cat. No. 1611).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.
Leach et al.
Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion.
Graham et al.
On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89.
Stefani et al.